Skip to main content

Advertisement

Log in

α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Extranigral non-motor signs precede the first motor manifestations of Parkinson’s disease by many years in some patients. The presence of α-synuclein deposition within colon tissues in patients with Parkinson’s disease can aid in identifying early neuropathological changes prior to disease onset. In the present study, we evaluated the roles of non-motor symptoms and signs and imaging biomarkers of nigral neuronal changes and α-synuclein accumulation in the colon. Twelve subjects undergoing colectomy for primary colon cancer were recruited for this study. Immunohistochemical staining for α-synuclein in normal and phosphorylated forms was performed in normally appearing colonic tissue. We evaluated 16 candidate premotor risk factors in this study cohort. Among them, ten subjects showed positive immunostaining with normal- and phosphorylated-α-synuclein. An accumulation of premotor markers in each subject was accompanied with positive normal- and phosphorylated-α-synuclein immunostaining, ranging from 2 to 7 markers per subject, whereas the absence of Lewy bodies in the colon was associated with relative low numbers of premotor signs. A principal component analysis and a cluster analysis of these premotor markers suggest that urinary symptoms were commonly clustered with deposition of peripheral phosphorylated-α-synuclein. Among other premotor marker, color vision abnormalities were related to non-smoking. This mathematical approach confirmed the clustering of premotor markers in preclinical stage of Parkinson’s disease. This is the first report showing that α-synuclein in the colon and other premotor markers are related to each other in neurologically normal subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Goldman JG, Postuma R (2014) Premotor and nonmotor features of Parkinson’s disease. Curr Opin Neurol 27:434–441

    Article  PubMed  PubMed Central  Google Scholar 

  2. Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72:893–901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lee HM, Koh SB (2015) Many faces of Parkinson’s disease: non-motor symptoms of Parkinson’s disease. J Mov Disord 8(2):92–97. doi:10.14802/jmd.15003

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sung HY, Park JW, Kim JS (2014) The frequency and severity of gastrointestinal symptoms in patients with early Parkinson’s disease. J Mov Disord 7:7–12

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liepelt-Scarfone I, Behnke S, Godau J, Schweitzer KJ, Wolf B, Gaenslen A, Berg D (2011) Relation of risk factors and putative premotor markers for Parkinson’s disease. J Neural Transm 118:579–585

    Article  CAS  PubMed  Google Scholar 

  6. Winkler J, Ehret R, Büttner T, Dillmann U, Fogel W, Sabolek M, Winkelmann J, Kassubek J (2011) Parkinson’s disease risk score: moving to a premotor diagnosis. J Neurol 258:S311–S315

    Article  PubMed  Google Scholar 

  7. Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alphasynuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72

    Article  CAS  PubMed  Google Scholar 

  8. Visanji NP, Brooks PL, Hazrati LN, Lang AE (2013) The prion hypothesis in Parkinson’s disease: Braak to the future. Acta Neuropathol Commun 1:2

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, Vrignaud S, Naveilhan P, Galmiche JP, Bruley des Varannes S, Derkinderen P, Neunlist M (2008) Pathological lesions in colonic biopsies during Parkinson’s disease. Gut 57:1741–1743

    Article  CAS  PubMed  Google Scholar 

  10. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N’Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P (2010) Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PLoS One 5:e12728

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH (2012) Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Mov Disord 27:709–715

    Article  PubMed  Google Scholar 

  12. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington

    Google Scholar 

  13. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord 22:2386–2393

    Article  PubMed  Google Scholar 

  14. Boeve BF, Molano JR, Ferman TJ, Smith GE, Lin SC, Bieniek K, Haidar W, Tippmann-Peikert M, Knopman DS, Graff-Radford NR, Lucas JA, Petersen RC, Silber MH (2011) Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med 12:445–453

    Article  PubMed  PubMed Central  Google Scholar 

  15. Koh SB, Kim JW, Ma HI, Ahn TB, Cho JW, Lee PH, Chung SJ, Kim JS, Kwon do Y, Baik JS (2012) Validation of the korean-version of the nonmotor symptoms scale for Parkinson’s disease. J Clin Neurol 8:276–283

    Article  PubMed  PubMed Central  Google Scholar 

  16. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312

    Article  PubMed  Google Scholar 

  17. Oh YS, Kim JS, Chung SW, Song IU, Kim YD, Kim YI, Lee KS (2011) Color vision in Parkinson’s disease and essential tremor. Eur J Neurol 18:577–583

    Article  PubMed  Google Scholar 

  18. Berg D, Siefker C, Becker G (2001) Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248:684–689

    Article  CAS  PubMed  Google Scholar 

  19. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases. Mov Disord 27:716–719

    Article  PubMed  Google Scholar 

  20. Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE (2014) Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson’s disease biomarker. Mov Disord 29:444–450

    Article  PubMed  Google Scholar 

  21. Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LW, Lang AE, Hazrati LN (2015) Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 84:609–616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Antunes L, Frasquilho S, Ostaszewski M, Weber J, Longhino L, Antony P, Baumuratov A, Buttini M, Shannon KM, Balling R, Diederich NJ (2016) Similar α-Synuclein staining in the colon mucosa in patients with Parkinson’s disease and controls. Mov Disord 31:1567–1570

    Article  CAS  PubMed  Google Scholar 

  23. Chung SJ, Kim J, Lee HJ, Ryu HS, Kim K, Lee JH, Jung KW, Kim MJ, Kim MJ, Kim YJ, Yun SC, Lee JY, Hong SM, Myung SJ (2016) Alpha-synuclein in gastric and colonic mucosa in Parkinson’s disease: limited role as a biomarker. Mov Disord 31:241–249

    Article  CAS  PubMed  Google Scholar 

  24. Gold A, Turkalp ZT, Munoz DG (2013) Enteric alpha-synuclein expression is increased in Parkinson’s disease but not Alzheimer’s disease. Mov Disord 28:237–240

    Article  CAS  PubMed  Google Scholar 

  25. Lebouvier T, Coron E, Chaumette T, Paillusson S, Bruley des Varannes S, Neunlist M, Derkinderen P (2010) Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil 22:e11–e14

    CAS  PubMed  Google Scholar 

  26. Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM (2014) Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord 29:991–998

    Article  CAS  PubMed  Google Scholar 

  27. Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R (2011) Parkinson disease: the enteric nervous system spills its guts. Neurology 77:1761–1767

    Article  CAS  PubMed  Google Scholar 

  28. Kim JS, Sung HY (2015) Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease. J Mov Disord 8:76–82

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221

    Article  CAS  PubMed  Google Scholar 

  30. Böttner M, Zorenkov D, Hellwig I, Barrenschee M, Harde J, Fricke T, Deuschl G, Egberts JH, Becker T, Fritscher-Ravens A, Arlt A, Wedel T (2012) Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol Dis 48:474–480

    Article  PubMed  Google Scholar 

  31. Pouclet H, Lebouvier T, Coron E, des Varannes SB, Rouaud T, Roy M, Neunlist M, Derkinderen P (2012) A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson’s disease. Neurobiol Dis 45:305–309

    Article  PubMed  Google Scholar 

  32. Erro R, Picillo M, Amboni M, Moccia M, Vitale C, Longo K, Pellecchia MT, Santangelo G, Martinez-Martin P, Chaudhuri KR, Barone P (2015) Nonmotor predictors for levodopa requirement in de novo patients with Parkinson’s disease. Mov Disord 30:373–378

    Article  CAS  PubMed  Google Scholar 

  33. van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25:969–978

    Article  PubMed  Google Scholar 

  34. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New Clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863–873

    Article  PubMed  Google Scholar 

  35. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Erro R, Picillo M, Vitale C, Palladino R, Amboni M, Moccia M, Pellecchia MT, Barone P (2016) Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. Parkinsonism Relat Disord 28:137–140

    Article  PubMed  Google Scholar 

  37. Ye Q, Wang TF, Peng YF, Xie J, Feng B, Qiu MY, Li LH, Lu AG, Liu BY, Zheng MH (2010) Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Oncol Rep 23:429–436

    CAS  PubMed  Google Scholar 

  38. Chahine LM, Daley J, Horn S, Colcher A, Hurtig H, Cantor C, Dahodwala N (2013) Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson’s disease. Mov Disord 28:1146–1149

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation in the program year of 2013.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joong-Seok Kim.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, JS., Park, IS., Park, HE. et al. α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects. Neurol Sci 38, 171–179 (2017). https://doi.org/10.1007/s10072-016-2745-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2745-0

Keywords

Navigation